Real-Vaso Survey:
Evaluation of the real world use of vasopressin in ICU
*
1.
Location
(Obligatoire)
Europe
USA/Canada
South America
Asian/Pacific
*
2.
Type of ICU
(Obligatoire)
Mixed PICU
Medical PICU
Surgical PICU
*
3.
Experience as intensivist
(Obligatoire)
Not specialized yet, in training
<2 y
2-5y
>5y
*
4.
Type of institution
(Obligatoire)
University Hospital
Non-university public hospital
Private Hospital
other
*
5.
Number of ICU beds
(Obligatoire)
<5
5-10
11-15
16-20
>20
*
6.
What is the nurse:patient ratio in you unit?
(Obligatoire)
1:1
1:2
1:2.5
1:3
1:4
Other
*
7.
Vasopressin introduction
In which situation would you not introduce vasopressin?
(Obligatoire)
History of GI vasculopathy
History of systemic sclerosis
History of vasospatic diseases (Raynaud disease, acrocyanosis, livedo reticularis)
History of peripheral vasculopathy
Peripheral malperfusion already present (digital ischemia, non-occlusive mesenteric ischemia)
Postoperative period with vascular anastomosis
None
*
8.
Feared secondary effects while using vasopressin?
(Obligatoire)
Digital ischemia
Digestive ischemia
Unclear impact on outcome
Hyponatremia
Cardiac arrhythmias
None
*
9.
If vasopressin is contraindicated, which vasopressor you would use?
(Obligatoire)
Norepinephrine
Epinephrine
Angiotensin II
Phenylephrine
Methylene blue
*
10.
In which situations you would mostly use vasopressin?
(Obligatoire)
Septic shock refractory to initial resuscitation
Septic shock with high risk of renal failure
Septic shock in a patient with ARDS
Septic shock in a cirrhotic patient
Septic shock with atrial arrhythmia
Refractory vasoplegic shock (other than septic) without reduced cardiac function
Refractory vasoplegic shock (other than septic) with reduced cardiac function
*
11.
At which step of resuscitation do you start vasopressin?
(Obligatoire)
First line vasopressor
Second line, after initial resuscitation using fluid and norepinephrine
Third line, as rescue therapy
Early in the vasopressive therapy to reach pressure goal and spare catecholamine in order to decrease catecholamine load
*
12.
What is you first line vasopressor?
(Obligatoire)
Norepinephrine
Epinephrine
Vasopressin
Angiotensin II
Phenylephrine
Methylene blue
Dopamine
*
13.
If vasopressin is your first line agent, what is your second line vasopressor?
(Obligatoire)
Norepinephrine
Epinephrine
Angiotensin II
Phenylephrine
Methylene blue
Dopamine
Vasopressin is not my first line vasopressor
*
14.
If vasopressin is your second line agent, what is your first line vasopressor?
(Obligatoire)
Norepinephrine
Epinephrine
Angiotensin II
Phenylephrine
Methylene blue
Dopamine
15.
If you do not use vasopressin as a second line agent, what is your second line vasopressor?
Norepinephrine
Epinephrine
Angiotensin II
Phenylephrine
Methylene blue
Dopamine
16.
If vasopressin is your third line agent, what is your second line vasopressor?
Norepinephrine
Epinephrine
Angiotensin II
Phenylephrine
Methylene blue
Dopamine
*
17.
If you have to choose a norepineprine dose as a trigger to initiate vasopressin, what dose would it be (Noradrenaline equivalent dose µg/kg/min)?
(Obligatoire)
none
0.25-0.5
0.5-1
1-2
2-5
*
18.
If you have to choose a duration of noradrenaline support as a trigger to initiate vasopressin, what duration would it be (hours of support)?
(Obligatoire)
<2h
2-4h
4-6h
6-8h
8-12h
>12h
*
19.
If you have to choose the association of dose and duration of noradrenaline support as a trigger to initiate vasopressin, what would it be (Noradrenaline equivalent dose µg/kg/min and duration of support)?
(Obligatoire)
0.25 for <2 hours
0.5 for <2 hours
1 for <2 hours
>2 for <2 hours
0.25 for 2-6 hours
0.5 for 2-6 hours
1 for 2-6 hours
>2 for 2-6 hours
0.25 for >6 hours
0.5 for >6 hours
1 for >6hours
>2 for >6 hours
*
20.
If you have to choose a clinical sign as a trigger to initiate vasopressin, what would it be?
(Obligatoire)
Persistent skin mottling
Oliguria
Persistent hyperlactatemia
Persistent low systolic arterial pressure
Persistent low mean arterial pressure
Persistent low diastolic arterial pressure
*
21.
If you have to use only one to trigger vasopressin therapy, which one would it be?
(Obligatoire)
Dose
Duration
Clinical signs
*
22.
Do you use a combination of those elements?
(Obligatoire)
Dose & duration
Dose & clinical response
Duration & clinical signs
Dose & Duration & Clinical signs & Clinical response
*
23.
What vasopressin starting dose do you use?
(Obligatoire)
0.0001 UI/kg/min
0.0005 UI/kg/min
0.001 UI/kg/min
Other (specify in next question)
24.
What vasopressin starting dose do you use (UI/kg/min) if not mention in the last question?
*
25.
What vasopressin dose do you use during the patient’s resuscitation?
(Obligatoire)
Fixed dose same as initial dose
Fixed dose at 0.01 UI/min
Fixed dose at 0.02 UI/min
Fixed dose at 0.03 UI/min
Fixed dose at 0.05 UI/min
Fixed dose at 0.06 UI/min
Fixed dose at 0.0001 UI/kg/min
Fixed dose at 0.01 UI/kg/min
Titration to clinical response
Other (specify in next question)
26.
What fixed vasopressin dose do you use during the patient’s resuscitation (UI/kg/min) if not mention in the last question?
*
27.
What is the maximal vasopressin dose you may use?
(Obligatoire)
0.03 UI/min
0.05 UI/min
0.06 UI/min
0.001 UI/kg/min
0.002 UI/kg/min
0.01 UI/kg/min
0.05 UI/kg/min
No maximal dose
Other (specify in next question)
28.
What is the maximal vasopressin dose you may use (UI/kg/min) if not mention in the last question?
*
29.
How do you manage the cessation of vasopressin support with another vasopressor?
(Obligatoire)
I stopped vasopressin in parallel to another vasopressor
I stopped vasopressin after norepinephrine or first line vasopressor regardless of the vasopressor use
I stopped vasopressin first
*
30.
How do you stop vasopressin support?
(Obligatoire)
Progressive decreasing of the vasopressin support
Abrupt cessation of the vasopressin support